
A leading provider of
innovative DNA Screening solutions
This is the most common rearrangement in AML and MDS and involves the deletion of a region of 5q including EGR1. This is thought to be a good candidate gene for these patients because, with interaction between it and the fibronectin, TGFB1 and plasminogen activator 1 genes it can inhibit cancer growth.
Cat. No. LPH 024-S (5 tests)
Cat. No. LPH 024 (10 tests)
This webpage could contain information on product details or information not valid in your country or region. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration or usage in the country of your origin. If you are a resident of a country other than those to which this site is directed, contact your local Cytocell distributor to obtain the appropriate product information for your country of residence.
Developed &